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ABSTRACT  
   
The hypothalamus pituitary adrenal (HPA) axis and the human genome 
are important components of the biological etiology of externalizing disorders. By 
studying the associations between specific genetic variants, diurnal cortisol, and 
externalizing symptoms we can begin to unpack this complex etiology. It was 
hypothesized that genetic variants from the corticotropine releasing hormone 
receptor 1 (CRHR1), FK506 binding protein 51 (FKBP5), catechol-O-methyl 
transferase (COMT), and dopamine transporter (DAT1) genes and diurnal cortisol 
intercepts and slopes would separately predict externalizing symptoms. It was 
also hypothesized that genetic variants would moderate the association between 
cortisol and externalizing. Participants were 800 twins (51% boys), 88.5% 
Caucasian, M=7.93 years (SD=0.87) participating in the Wisconsin Twin Project. 
Hierarchical Linear Modeling (HLM) was used to separate the variance associated 
with state and trait cortisol measured across three consecutive days and trait 
cortisol measures were used. There were no main effects of genes on 
externalizing symptoms. The evening cortisol intercept, the morning cortisol 
slope and the evening cortisol slope predicted externalizing, but only in boys, 
such that boys with higher cortisol and flatter slopes across the day also had more 
externalizing symptoms. The morning cortisol intercept and CRHR1 rs242924 
interacted to predict externalizing in both boys and girls, with GG carriers 
significantly higher compared to TT carriers at one standard deviation below the 
mean of morning cortisol. For boys only there was a significant interaction 
between the DAT1 variable number tandem repeat (VNTR) and the afternoon 
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slope and a significant slope for 9/9 carriers and 9/10 carriers such that when the 
slope was more steep, boys carrying a nine had fewer externalizing symptoms but 
when the slope was less steep, they had more. Results confirm a link between 
diurnal trait cortisol and externalizing in boys, as well as moderation of that 
association by genetic polymorphisms. This is the first study to empirically 
examine this association and should encourage further research on the biological 
etiology of externalizing disorder symptoms. 
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Genes Moderate the Association of Trait Diurnal Cortisol and Externalizing 
Symptoms in Boys 
Conduct disorder (CD) and oppositional defiance disorder (ODD) are 
relatively common childhood externalizing disorders characterized by aggressive 
and delinquent behaviors (American Psychiatric Association, 2000). Early 
externalizing symptoms are associated with later development of externalizing 
disorders and a lifetime of delinquent behavior (Moffitt, 1993). Behavioral 
differences for children who go on to develop externalizing disorders have been 
observed as early as the infancy period (Olson et al., 1999), but middle childhood 
is a critical time when the negative consequences of these disorders appear to be 
both concurrent and far-reaching. For elementary school-aged children, 
externalizing symptoms predict poorer self-esteem (Zhou et al., 2010), and poorer 
relationships with parents, siblings, and peers compared to their healthy 
counterparts (Hymel, Rubin, Rowden, & Lemare, 1990; Richmond & Stocker, 
2006). Externalizing symptoms in children at age eight predict delinquency and 
substance abuse in adolescence and adulthood (Fergusson, Horwood, & Ridder, 
2005; Fergusson & Lynskey, 1998).  
Approximately two to three percent of children in middle childhood have 
a diagnosis of CD or ODD across a three month window (Costello et al., 2003). 
Between the ages of nine and 16, cumulative prevalence rates are nine percent for 
CD (3.8% for girls and 14.1% for boys) and 11 percent for ODD (9.1% for girls 
and 13.4% for boys), making externalizing disorders a common health concern. In 
order to prevent the manifestation of symptoms that may lead to externalizing 
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disorders and address the risk of negative outcomes associated with externalizing 
disorders, it is crucial to understand biological and psychological mechanisms that 
underlie their development.  
The hypothalamic-pituitary-adrenal (HPA) axis, a key component of the 
human neuroendocrine system that regulates the biological reaction to stress, has 
shown potential as a mechanism underlying externalizing behaviors via its 
regulation of the stress hormone cortisol (Alink et al., 2008; Tuttle et al., 2011). 
The physiological pathways by which cortisol acts to influence externalizing 
behaviors are not fully understood, but evidence is accumulating in support of a 
neurobiological model in which the HPA axis plays a crucial role in the 
development of externalizing symptoms (van Goozen, Fairchild, Snoek, & 
Harold, 2007). Animal research supports two different biological pathways from 
HPA axis functioning to externalizing symptoms. The first is a reactive 
aggression pathway. Stress activates the hypothalamus which activates the HPA 
axis, and the resulting cortisol leads to an increase in feelings of anxiety (Kruk, 
Halasz, Meelis, & Haller, 2004). This increase in anxious feelings in children 
leads to acting out in ways that would be classified as externalizing symptoms. 
The second pathway is what van Goozen et al (2007) call the abnormal aggression 
pathway. When corticosterone, an animal hormone equivalent to cortisol in 
humans, was controlled in rodents, such that corticosterone exposure was 
abnormally low, the rodents were unable to correctly interpret social cues and 
behaved with abnormally high levels of aggression (Haller et al., 2001). 
Translating these findings to the application of human research, it may be useful 
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to differentiate between externalizing symptoms as the result of anxiety brought 
on by biological reactions to high or chronic stress, and externalizing symptoms 
born from low levels of cortisol leading to an inability to correctly interpret 
environmental cues. The current study attempted to differentiate between these 
two etiological pathways by distinguishing between comorbid externalizers 
(children with symptoms of both externalizing and anxiety) and “pure” 
externalizers (children with externalizing without anxiety symptoms). Both higher 
cortisol reactivity in response to stress, and dysregulated cortisol patterns 
measured across a typical day (diurnal cortisol) have been associated with 
externalizing symptoms in children (Alink et al., 2008).  
The HPA-axis and Diurnal Cortisol as Biological Underpinnings of 
Externalizing Symptoms 
 Attempts to understand the contributions of the HPA-axis to externalizing 
behaviors through the measurement of diurnal cortisol have been met with 
conflicting results. Studies have linked externalizing to both heightened (hyper) 
and muted (hypo) patterns of cortisol activity throughout the day (Alink et al., 
2008). From a theoretical perspective, understanding these discrepant patterns is 
crucial to differentiating between reactive and abnormal aggression pathways.  
Many factors have been explored to explain these discrepancies, including 
the age of participants, gender, reactive (cortisol measured after exposure to a 
specific stressor) vs. diurnal (cortisol measured at multiple time points across a 
typical day) measures of cortisol, and clinical vs. normal population samples. 
Meta-analysis of the literature yielded associations between diurnal cortisol, but 
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not reactive cortisol, and externalizing symptoms (Alink et al., 2008). Only 
participant age consistently moderated the association between cortisol and 
externalizing. Specifically, higher levels of diurnal cortisol (hypercortisolism) was 
associated with externalizing in preschoolers, lower levels (hypocortisolism) was 
associated with externalizing in middle childhood, and cortisol was not associated 
with externalizing in adolescents. 
A more recent factor that has been explored in relation to the cortisol-
externalizing association is the variance in cortisol related to “trait-like” sources 
and the variance related to “situation specific” sources of variance (Kirschbaum et 
al., 1990; Shirtcliff, Granger, Booth, & Johnson, 2005). The logic is that variance 
in cortisol must arise from three sources: person factors (traits), person-situation 
interactions (states), and measurement error, and that separating trait and state-
like variance allows a more in-depth study of cortisol. State cortisol variance 
ranged from 52-75 percent of the total variance, and trait cortisol variance ranged 
from 19-46 percent, with lower trait cortisol found only in boys high in 
externalizing symptoms, but no reported association with state cortisol (Booth, 
Granger, & Shirtcliff, 2008; Shirtcliff et al., 2005). 
The “trait-like” component of variance of particular interest in this study is 
the genetic influence on the HPA-axis. Previous work has shown heritability 
estimates of morning cortisol in children to be as high as 60 percent (Bartels, de 
Geus, Kirschbaum, Sluyter, & Boomsma, 2003; Wust, Federenko, Hellhammer, 
& Kirschbaum, 2000), suggesting an important genetic component to HPA axis 
functioning. The influence of genetics on diurnal cortisol is not the same 
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throughout the day. Morning cortisol has a significant additive genetic component 
that extends to the slope from morning to afternoon cortisol, but the slope from 
afternoon to evening cortisol does not have a significant genetic component (Van 
Hulle, Shirtcliff, Lemery-Chalfant, & Goldsmith, 2012). Morning, afternoon, and 
evening measures have a significant influence of the shared environment in 
common. Concentrating on the variance associated with trait cortisol throughout 
the day focuses the current study on aspects of diurnal cortisol most likely to have 
strong genetic influences, by testing morning cortisol, and the aspects that are 
more environmentally driven, by testing afternoon and evening measures, all 
while eliminating the variance that fluctuates from day to day. 
Genetic Influences on the HPA-axis and Externalizing Symptoms Association 
Genetic differences, through their impact on biological systems both 
integral and peripheral to HPA-axis functioning, have the potential to act as 
moderators of the association between diurnal trait cortisol and externalizing 
symptoms. Previous research has separately found both externalizing disorders 
(Dick, Viken, Kaprio, Pulkkinen, & Rose, 2005) and diurnal cortisol (Van Hulle 
et al., 2012) to be moderately heritable, but it is not yet clear from twin and 
molecular genetic research if the association between externalizing and cortisol 
may vary by genetic background. Catechol-O-methyl transferase (COMT), and 
dopamine transporter (DAT1) genes have been associated with externalizing 
behaviors (Albaugh et al., 2010; Schmidt, Fox, & Hamer, 2007; Young et al., 
2002). In addition, FK506 binding protein 51 (FKBP5), corticotropin releasing 
hormone receptor 1 (CRHR1), COMT, and DAT1 genes have all been associated 
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with the HPA-axis (Alexander et al., 2011; Chen, Joormann, Hallmayer, & 
Gotlib, 2008; Gillespie, Phifer, Bradley, & Ressler, 2009; Ising et al., 2008).  
Understanding the moderating effects of genes in the cortisol-externalizing 
association is an integral step in understanding the mechanisms at work in the 
development of externalizing symptoms. The goal of this project is to understand 
how polymorphisms of the FKBP5, CRHR1, COMT, and DAT1 genes are 
associated with externalizing and moderate the relation between trait diurnal 
cortisol and externalizing symptoms in middle childhood. 
Reactive Aggression vs. Abnormal Aggression 
 It is first crucial to understand whether the cortisol-externalizing pathway 
is better classified as reactive or abnormal. The reactive aggression pathway can 
be tested with a diathesis-stress model. According to the diathesis-stress model 
there are two components necessary for developing a disorder: a diathesis (in this 
case a genetic susceptibility) and stress (in this case exposure to dysregulated 
cortisol) (Monroe & Simmons, 1991). Even though diurnal cortisol activity is 
somewhat heritable in the morning, there is evidence in the literature that cortisol 
can act as an epigenetic factor to activate or deactivate gene expression (Lee et al., 
2010). The abnormal pathway, in contrast, is brought on by a biological deficit, in 
this case a lack of cortisol affecting the child’s ability to accurately interpret and 
respond to social cues.  
One method for distinguishing between these two pathways is to consider 
the impact of anxiety symptoms as a covariate. In line with two independent 
pathways, children with CD or ODD have been found to be fundamentally 
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different based on whether they were comorbid for an anxiety disorder (Walker et 
al., 1991). Children with an anxiety comorbidity had fewer symptoms and were 
less severely impaired by their externalizing disorder compared to children with 
externalizing without the comorbidity. Children displaying externalizing 
symptoms because of the abnormal pathway can be considered “pure” 
externalizers, displaying symptoms of externalizing without also exhibiting 
symptoms of anxiety. Symptoms of anxiety, in this case, would be associated with 
the reactive pathway. In other words, children who display symptoms of 
externalizing for reactive reasons are responding to chronic stress that may also 
result in anxiety symptoms, and can be considered “comorbid” externalizers. By 
controlling for the impact of comorbid anxiety symptoms, one goal of the current 
study was to understand the predominate pathway through which externalizing 
symptoms arise for children during middle childhood. If results in the current 
study are only significant when anxiety is controlled, it would suggest support for 
the abnormal aggression pathway. On the other hand, if findings are only 
significant when anxiety symptoms are not controlled for, it would suggest 
support for the reactive aggression pathway. 
Stress-reactive Genes 
CRHR1. CRHR1, or corticotropin releasing hormone receptor 1, is a gene 
with strong links to the HPA-axis and cortisol. Neurons in the paraventricular 
nucleus of the hypothalamus send out signals that cause the hypothalamus to 
release corticotropin releasing hormone (CRH) into the blood where it travels to 
the anterior pituitary gland and activates CRH1 receptors (Gillespie et al., 2009; 
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Swanson et al., 1983). Activation of the CRH1 receptors causes an increase in the 
secretion of adrenocorticotrophic hormone (ACTH) which stimulates the release 
of cortisol. CRHR1, as the gene that dictates the number of CRH1 receptors, is of 
particular interest to researchers studying the HPA-axis stress response. CRHR1 
has been implicated in the development of mood disorders through its influence 
on the activity of the CRH system (Bradley et al., 2008; Reul & Holsboer, 2002). 
Very few studies so far have drawn a link between this gene and 
externalizing behavior. In rhesus monkeys, genetic differences in a CRHR1 
haplotype, an allelic combination of adjacent chromosome locations that transmit 
together, were associated with CRH in the blood, and bold behavior and alcohol 
consumption (Barr et al., 2008). In humans, alcohol consumption, which is related 
to externalizing behaviors, is associated with stress and the CRHR1 gene such 
that greater stress and homozygosity for the C allele of CRHR1 SNP rs1876831 
predicted earlier onset of drinking and greater amounts of alcohol consumption 
(Schmid et al., 2010). 
The influence of this gene on the upregulation of CRH receptors links it to 
the production of cortisol and makes it a strong candidate for contributing to the 
dysregulated daily cortisol patterns associated with externalizing behaviors in 
middle childhood. If the G allele of the rs242924 SNP is associated with higher 
levels of cortisol, then it may play a role in the link between hypocortisolism and 
externalizing behaviors. 
FKBP5. The FKBP5, also known as FK506 binding protein 51 gene, like 
CRHR1 is known to influence HPA-axis functioning and cortisol. Cortisol is 
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integral to the negative feedback process that downregulates the HPA axis’ stress 
response (Binder, 2009). Cortisol binds with glucocorticoid receptors (GR) to 
initiate the negative feedback loop. FKBP5 binds to GRs and puts them into a low 
binding affinity state.  When GRs are in this low binding affinity state, they are 
less sensitive to cortisol and it requires higher levels of cortisol to initiate the 
negative feedback loop. GRs are nuclear receptors that, after binding with 
cortisol, translocate to the cell nucleus where they mediate mRNA production for 
genes associated with neuronal activation and plasticity by binding to 
transcription factors (Maccari et al., 1992; Pavlides et al., 1995). Tatro et al 
(2009) inhibited FKBP5 in cells, which led to increased nuclear localization 
(travel to the nucleus) of GRs.  Based on these studies, changes in FKBP5 mRNA 
expression might affect behavior through differences in neuronal activation and 
plasticity. This process could be particularly important when considering the 
epigenetic influence of cortisol on this gene. 
Epigenetics is the study of changes in the expression of DNA that do not 
affect the underlying DNA sequence (Meaney, 2010). Methylation is an 
epigenetic process by which gene expression is either prevented or reduced. In 
research with mice, increases in corticosterone have been shown to decrease 
FKBP5 methylation and increase mRNA expression over two-fold (Lee et al., 
2010). Similarly, in rat brains an increase in FKBP5 mRNA expression was also 
shown when increases in corticosterone were brought on by stress (Scharf, Liebl, 
Binder, Schmidt & Muller, 2011). The association between corticosterone and 
FKBP5 methylation and expression found in these studies suggests a utility in 
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testing cortisol as an epigenetic factor moderating the relationship between 
FKBP5 and phenotypic outcomes in humans, such as externalizing behaviors. 
FKBP5 expression in humans has been found to be influenced by 
rs1360780; a T for C base substitution SNP in the FKBP5 gene (Binder, 2009). 
Homozygosity for the T allele of this SNP is associated with protein expression 
twice as high as C allele carriers. Previous research has associated this SNP with 
depression and anxiety (Binder et al., 2004; Binder et al., 2008; Zimmerman et 
al., 2011). It has also been found to interact with neglect during childhood to 
predict increased reactivity in the amygdala during magnetic resonance imaging 
(MRI) (White et al., 2012). 
Researchers have yet to tackle, however, the possible involvement of this 
gene in the etiology of externalizing disorders. If school-aged children with 
externalizing problems have hypocortisolism, as previous research suggests, this 
pattern may indicate two possible pathways by which FKBP5 may interact with 
diurnal cortisol to predict externalizing. First, children with the C allele and 
hypocortisolism may be the most likely to demonstrate symptoms of externalizing 
because hypocortisolism associated with less FKBP5 mRNA expression coupled 
with a genotype already associated with less FKBP5 protein expression means 
these children can more quickly turn off their stress response and feel less stress 
in response to their aggressive actions. Second, if we consider the findings of 
Velder et al (2011) that the T allele is associated with a lower cortisol AUC, 
perhaps children with the T allele and hypocortisolism have higher externalizing 
because their cortisol response is not increasing to fulfill the higher requirement to 
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activate the negative feedback loop, putting them in a prolonged period of 
physiological stress resulting in externalizing symptoms.  
Catecholamine Genes 
 COMT. Research has identified genes influencing catecholamines, the 
most common of which in the human brain are dopamine, epinephrine, and 
norepinephrine, as potential indirect influences on the HPA-axis (Alexander et al., 
2011). The catechol-O-methyl transferase (COMT) gene regulates catecholamines 
by encoding an enzyme that breaks them down in the synapses (Grossman, 
Emanuel, & Budarf, 1992). Catecholamines have an impact on the HPA-axis 
through their influence on brain structures that contribute to the regulation of the 
HPA-axis, such as the limbic system and the prefrontal cortex (Jankord & 
Herman, 2008). Using a rat model, Ginsberg et al (2011) found up regulation of 
COMT in the cerebellum, frontal cortex, hippocampus, midbrain, and striatum of 
submissive rats using a resident-intruder paradigm. In the aggressive rats they 
discovered down regulation of COMT in the hippocampus. In humans, the rs4680 
SNP is a valine (val) to methionine (met) substitution (Lachman et al., 1996). The 
Met allele of this SNP is associated with increased dopamine in the prefrontal 
areas of the brain compared to the Val (Sesack et al., 1998). 
One important consideration with the functioning of this gene is the body 
of literature suggesting that it has a sexually dimorphic effect. In mice, males 
without the COMT gene were found to have a 2-3 fold increase in dopamine in 
the frontal cortex whereas female mice without the COMT gene showed no 
difference in dopamine levels (Gogos et al., 1998). In humans, COMT activity has 
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been shown to be greater in male brains even when COMT expression in male 
and female brains is equivalent (Chen et al., 2004). Differences in estrogen and 
dopamine functioning between men and women have been proposed as possible 
explanations for this sex difference; however, the exact cause of the sex disparity 
in COMT activity is not fully understood (Harrison & Tunbridge, 2008). The 
implications of this difference appear to be different depending on the phenotype 
of interest but what is clear is that sex should be treated as a moderator when 
considering this gene (Harrison & Tunbridge, 2008). 
There is a sizable literature relating rs4680 with externalizing behavior. 
The Val allele has been associated with CD symptoms in a sample of adolescents 
(DeYoung et al., 2010). In children with ADHD, the Met allele has been most 
commonly associated with antisocial behaviors (Caspi et al., 2008; Thapar et al., 
2005). Mothers have also been found to rate their children higher on the 
aggressive behavior scale of the Child Behavior Checklist when their children had 
a Met allele compared to Val homozygotes (Albaugh et al., 2010).  
It remains to be seen how the rs4680 SNP might moderate the association 
between diurnal cortisol and externalizing symptoms in the present study. With 
previous findings associating the Met allele with both higher externalizing related 
outcomes and higher levels of both reactive and diurnal cortisol, it remains 
unclear how this relates to Alink et al.’s (2008) finding that externalizing is 
associated with lower levels of cortisol during middle childhood. 
DAT1. The dopamine transporter (DAT) is a protein that binds to 
dopamine molecules in the synapses and reuptakes them back into nerve terminals 
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(Torres, Gainetdinov, & Caron, 2003). The dopamine transporter gene (DAT1) 
possesses a VNTR of which the 10-repeat allele and the 9-repeat allele are the 
most common (Heinz et al., 2000). The 9-repeat allele has been associated with 
reward-related activity in the ventral striatum (the piece of the striatum associated 
with the limbic system) (Forbes et al., 2009). The 10-repeat allele has been 
associated with increased post-mortem levels of DAT in the mid-brain (Brookes 
et al., 2007).  
Reports on the functionality of the DAT1-VNTR have been mixed. Mill, 
Asherson, Craig, and D’Souza (2005) found no difference in gene expression 
between the 9 and 10-repeat alleles. VanNess et al. (2005), on the other hand, 
found that participants with the 10-repeat allele had 50 percent more DAT binding 
site density compared to participants with the 9-repeat. More recently, van de 
Giessen and colleagues (2009) found the 9-repeat allele to be associated with 
higher striatal DAT levels compared to the 10-repeat.  
DAT1 has been associated with aggression. In adolescents, having the 10-
repeat and fewer friends involved in criminal activity predicted increased violent 
aggression and criminal recidivism (Vaughn et al., 2009). Guo et al (2007) found 
a main effect of the DAT1-VNTR such that boys with a copy of the 10-repeat 
were nearly twice as high on self-reported violent delinquency scores compared to 
9-repeat homozygotes and this difference was stable from the age of 12 to 23 
years. Evidence in young and middle childhood, however, suggests that the 9-
repeat may be the risk factor for younger children (Young et al., 2003). At ages 
four and seven, carriers of the 9-repeat were significantly more likely to show 
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symptoms of mother reported externalizing compared to children with the 10-
repeat. 
The Proposed Study 
The general purpose was to understand main effect associations between 
genetic polymorphisms and symptoms of externalizing disorders and to 
understand the potential moderating influence of polymorphisms on the 
association between diurnal cortisol and symptoms of externalizing disorders, 
while controlling for symptoms of anxiety. Researching potential interactions 
between genes and an integral physiological system, such as the HPA-axis 
through the measurement of diurnal cortisol, may help uncover the etiology of 
externalizing symptoms. I tested two sets of hypotheses: 
Hypothesis 1: Main Effects of Genetic Polymorphisms and Diurnal Cortisol 
on Externalizing Symptoms 
1a) I hypothesized that children would have significant differences in 
externalizing symptoms because of allelic differences in CRHR1 SNP rs242924, 
FKBP5 SNP rs1360780, COMT SNP rs4680, and the DAT1-VNTR. 
1b) I hypothesized that children lower (intercepts) or flatter (slopes) on each trait 
diurnal cortisol measure would have more externalizing symptoms. 
 
Hypothesis 2: Genetic Polymorphisms Moderate Diurnal Cortisol and 
Externalizing Symptom Associations 
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2) I hypothesized that genetic polymorphisms in CRHR1 SNP rs242924, FKBP5 
SNP rs1360780, COMT SNP rs4680, and the DAT1-VNTR would interact with 
diurnal cortisol to predict externalizing symptoms in children. 
Method 
Participants 
Monozygotic and dizygotic twin pairs were recruited from Wisconsin 
birth records as part of the Wisconsin Twin Project (WTP). The WTP is a large 
multi-phase longitudinal twin study that seeks to understand the development of 
temperament, emotions, psychopathology and other behavioral and biological 
phenotypes from birth to adolescents (Schmidt et al., 2013). A subset of the full 
WTP sample was selected at age seven in order to achieve a balance of children 
with externalizing, internalizing, and comorbid disorders, as well as a control 
sample of healthy children, and all cotwins. Eight-hundred twins (400 pairs) and 
their families recruited during infancy between 1989 and 2004 participated at this 
phase and provided genetic data.  
The sample is predominantly Caucasian (88.5%). Other ethnicities include 
African American (4.1%), mixed ethnicity (5.8%), Native American (0.3%), and 
Hmong (0.1%). The mean age is 7.93 (SD = .087 years) and 51% are boys. 
Monozygotic twins made up 32.2 percent of the sample, 33.4% were same sex 
dizygotic twins, and 34.4% were opposite sex dizygotic twins. Total family 
income ranged from unemployment to over $200,000 a year. The median income 
was $60,000 to $70,000 a year. Parent’s level of education ranged from no formal 
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education to a graduate degree, with most parents having completed some or all of 
a college degree (M mothers = 14.88 years of school, M fathers = 14.43). 
Measures  
Socio-economic Status (SES). Total family income, mother education, 
and father education were found to be moderately correlated (r’s = .45-.55, 
p<.0001). A mean composite was formed from the three measures after 
standardization of scales. SES was tested as a covariate. 
Externalizing Symptoms. Scores on CD and ODD were obtained from the 
primary caregiver for each twin separately at age seven using the Diagnostic 
Interview Schedule for Children IV (DISC-P) (Shaffer, Fisher, Lucas, Dulcan, & 
Schwab-Stone, 2000). The DISC-P is a 40-70 minute interview designed to assess 
child psychopathology within the previous year. The DISC-P is highly structured, 
with a branching tree question structure. Responses to questions in the DISC-P 
are almost always limited to “yes”, “no”, and “maybe”. Validity for the DISC-IV 
has not been formally tested, but for previous versions of the DISC-P validity 
ranged from .40 to .74 when comparing DISC diagnoses to clinician evaluations 
(Hersen, 2004). CD and ODD symptom count scales were moderately correlated 
(r = .50). For the purposes of this study, CD and ODD scales were used to form a 
sum externalizing symptom composite. Reliability for the externalizing composite 
was serviceable (α = .61). 
Anxiety. The general anxiety symptom count scale was also taken from 
the DISC-P. Reliability for the general anxiety scale has previously been found to 
be decent (α = .65) (Shaffer et al., 2000). 
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Diurnal Cortisol. Hierarchical linear modeling was used to separate the 
variance associated with state and trait cortisol measured across three consecutive 
days for all diurnal cortisol measures (Van Hulle, Shirtcliff, Lemery-Chalfant, & 
Goldsmith, 2012). This was done by taking the samples from each of the three 
days cortisol was collected and separating the variance that is consistent across 
the three days (trait cortisol) from the variance that changed across the days (state 
cortisol). This allowed for the formation of intercept and slope variables using 
trait cortisol. The diurnal cortisol intercepts are the individual cortisol measures 
taken at three time points throughout the day. They include the morning intercept 
measured at waking, the afternoon intercept measured seven hours after waking, 
and the evening intercept measured 14 hours after waking. Diurnal cortisol slopes 
were calculated using the intercepts to form the morning slope (the slope from the 
morning intercept to the afternoon intercept) and the afternoon slope (the slope 
from the afternoon intercept to the evening intercept). The current study used the 
morning and evening cortisol intercepts, as well as the morning and afternoon 
cortisol slopes. 
Genes. CRHR1 was measured using SNP rs242924. FKBP5 was 
measured using SNP rs1360780. COMT was measured using SNP rs4680. DAT1 
was measured using the DAT1-VNTR located at the 3’ end of the DAT1 gene. 
SNPs and VNTRs were coded additively. Because there is little known about how 
these SNPs and VNTRs may operate, and even less known about how they might 
function together, each gene was analyzed separately. All SNPs and VNTRs were 
found to be in Hardy-Weinberg Equilibrium (see Table 1), indicating that allelic 
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frequencies for the sample were in line with expected frequencies from the 
general population. 
Procedures 
 SES. Phone interviews were conducted with the twins’ primary caregiver 
when the twins were age seven. During these phone interviews, research staff 
administered demographics questionnaires that asked for family income and years 
of education of both parents. 
 Externalizing & Anxiety. Participating families took part in a four-five 
hour home visit during which research staff administered the DISC-P to the 
primary caregiver, separately for each twin. 
Salivary cortisol. Diurnal cortisol was collected three times a day for three 
consecutive days from each twin. Cortisol was collected through passive drool. 
Each twin was instructed not to eat or drink an hour before sampling. Parents 
collected saliva from their twins using salivettes, tagged the salivettes with the 
date and time, and stored the salivettes in their freezer until salivettes were 
retrieved by research staff at the home visit. Samples were collected at waking, 
seven hours after waking (afternoon), and 14 hours after waking (evening).  
In order to assay the cortisol, samples were centrifuged for 10 minutes at 
5000 rpm to remove impurities. Salivary enzymeimmunoassay kits (Salimetrics, 
State College, PA), used in duplicate, were used to assess the cortisol samples. 
Internal controls were included in each assay. For the low control, the average 
value was 0.082 μg/dL with inter- and intra-assay Coefficent of Variations (CVs) 
of 7.2% and 6.1%, respectively. For the high control, the average value was 0.84 
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μg/dL with inter- and intra-assay CVs of 8.1% and 5.3% respectively. The CV of 
the duplicates had to be < 20% for the results to be considered suitable.  
Genotyping. Cheek swabs were used to collect buccal cells for DNA 
testing at the home visits. MasterPure DNA kits obtained from Epicentre 
Biotechnologies at the Translational Genomics Research Institute (for SNP data) 
and the University of Wisconsin-Madison Biotechnology Center (for VNTR data) 
were used to extract DNA. Individual genotyping for SNP data was done using 
Sequenom technology. Sequenom technology directly reads the base sequences 
that make up the DNA strands. Eleven plates Direct Lysis Plasmid96 DNA 
Purification Kits that included four randomly chosen intraplate replicates and two 
positive CEPH (Centre d’etude du polymorphisme humain) controls from the 
Utah reference sample (CEU) of the International HapMap Consortium (2005) 
were used. HAPMAP concordance and the identification of Mendelian errors 
were accomplished by the addition of a plate of CEPH trios into each plex. VNTR 
genotyping was performed on agarose gels or via capillary electrophoresis. 
Agarose gels are used in a process called gel electrophoresis. Gel electrophoresis 
and capillary electrophoresis are methods used to separate fragments of DNA by 
length. 
Results 
Preliminary Analyses 
All variables were within West, Curran, and Finch’s (1995) guidelines for 
skewness and kurtosis. Multivariate outliers were tested using Mahalanobis D² 
(Cohen, Cohen, Aiken, & West, 2002). and no significant outliers were found. 
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 Age, sex, and SES were examined as covariates in all models, both as 
main effects and in interactions with the predictors. Age and SES were 
nonsignificant covariates across all models, and were thus dropped.  Main and 
interactive effects of sex were often significant, and interactions were probed 
using procedures outlined by Aiken and West (1991). In the case of significant 
three-way interactions, follow up analysis were conducted to elucidate the nature 
of the interactions. Specifically, when three-way interactions with sex were 
significant, they were followed up by testing the model again separately for boys 
and girls. 
 DISC general anxiety symptoms were controlled for in every model. This 
was done in order to inform whether the reactive aggression or abnormal 
aggression pathway was most influential on the current findings. Models in which 
results changed based on the inclusion of anxiety symptoms are noted below. 
Means and standard deviations for the morning and evening cortisol 
intercepts and slopes, as well as DISC general anxiety symptoms and 
externalizing symptoms and the covariates are reported in Table 2. As expected, 
the highest levels of cortisol came at the beginning of the day. The means of the 
morning and afternoon slopes indicate on average that cortisol is decreasing 
throughout the day which is consistent with the evening intercept having a lower 
mean than the morning intercept, and is in line with previous research with this 
age group.  
Zero-order correlations are presented in Table 3. The morning cortisol 
intercept was positively, but moderately correlated with the evening cortisol 
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intercept and negatively correlated with the morning and afternoon cortisol 
slopes, suggesting that higher morning cortisol is associated with steeper cortisol 
slopes and vice versa. The evening cortisol intercept, morning cortisol slope, and 
afternoon cortisol slope were all highly positively correlated with each other. 
DISC general anxiety symptoms were moderately positively correlated with DISC 
externalizing symptoms. Age was positively correlated with the evening cortisol 
intercept and both cortisol slopes. Genetic polymorphisms were not significantly 
correlated with other measures. 
 
Hypothesis 1: Genetic Polymorphisms and Diurnal Cortisol Predict 
Externalizing Symptoms 
 Multilevel regression in SPSS Statistics 20 (IBM, Inc., 2011) was used to 
regress externalizing symptoms on cortisol and candidate genetic polymorphisms. 
This method accounts for the independence violation of using twins as 
participants by controlling for the within dyad correlation (in this case the 
correlation between cotwins on externalizing symptoms). Each SNP and VNTR 
was tested in a separate model. Likewise each measure of diurnal cortisol was 
considered in a separate model. There were no main effects of CRHR1, FKBP5, 
COMT, or DAT1 on children’s externalizing symptoms (See Table 4). None of 
the genetic polymorphisms were found to interact with sex, SES, or age to predict 
externalizing symptoms. 
 Models predicting externalizing symptoms from cortisol measures are 
reported in Table 4. Whereas the morning cortisol intercept did not predict 
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externalizing symptoms, the evening cortisol intercept interacted with sex to 
predict externalizing symptoms. Further probing of the interaction found the slope 
for boys (β = 1.1665, s.e. = 0.438, z = 2.6635, p = .0077) was significant, such 
that boys with higher evening cortisol had greater externalizing symptoms (See 
Figure 1). Similarly, the morning and afternoon cortisol slopes interacted with sex 
to predict externalizing symptoms. Probing of the interaction found the slopes for 
boys (morning: β = 24.3084, s.e. = 9.9345, z = 2.4469, p = .0144; afternoon: β = 
9.5291, s.e. = 3.5038, z = 2.7197, p = .0065) were significant such that boys with 
a less steep decline in cortisol had greater externalizing symptoms (See Figures 2 
and 3).  
 
Hypothesis 2: Genetic Polymorphisms Moderate Diurnal Cortisol and 
Externalizing Symptom Associations 
 Multilevel regression in SPSS Statistics 20 (IBM, Inc., 2011) was used to 
test moderating associations. Product terms were formed by first centering the 
four cortisol measures. CRHR1 SNP rs242924 was found to interact with the 
morning cortisol intercept to predict externalizing symptoms (See Table 5 and 
Figure 4). The slope for GG carriers was marginal (β =  -1.4822, s.e. = 0.8748, z = 
-1.6944, p = .0902). Regions of significance testing revealed that GG carriers 
were significantly different from TT carriers at one standard deviation below the 
mean for morning cortisol (β =  -1.2731, s.e. = 0.3206, z = -3.9704, p = .0001). 
There was no significant difference at one standard deviation above the mean (β =  
-0.4044, s.e. = 0.3206, z = -1.2612, p = .2073). No significant interactions were 
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found with CRHR1 SNP rs242924 and any of the other three cortisol measures 
(See Table 6). 
No significant interactions were found between FKBP5 SNP rs1360780 
and any of the four cortisol measures when predicting externalizing symptoms 
(See Table 7). 
No interactions were significant between the COMT Val/Met and any of 
the four cortisol measures when predicting externalizing symptoms (See Table 8). 
The DAT1-VNTR, the morning intercept, and sex interacted to 
significantly predict externalizing symptoms (See Table 9). Follow up analysis 
with boys revealed a marginal interaction and a marginal slope for 9/9 carriers (β 
=  -1.4822, s.e. = 0.8748, z = -1.6944, p = .0902) such that at lower levels of 
morning cortisol, boys with the 9/9 genotype had more externalizing symptoms 
(See Figure 5). Region of significance testing found no significant differences at 
either one standard deviation below the mean (β =  -1.0006, s.e. = 0.8872, z = -
1.1279, p = .2594) or one standard deviation above the mean (β =  1.4219, s.e. = 
0.8872, z = 1.6027, p = .109) on morning cortisol. No interaction was found 
between the DAT1-VNTR and the morning intercept for girls.  The DAT1-VNTR 
and the afternoon slope were also found to interact with sex to predict 
externalizing symptoms (See Table 10).  Follow up analysis with boys resulted in 
a significant interaction between the DAT1-VNTR and the afternoon slope and a 
significant slope for 9/9 carriers (β =  37.4428, s.e. = 10.098, z = 3.7079, p = 
.0002) and 9/10 carriers (β =  19.9677, s.e. = 5.9536, z = 3.3539, p = .0008) such 
that when the slope was more steep, boys carrying a nine had fewer externalizing 
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symptoms but when the slope was less steep, they had more (See Figure 6). This 
association became marginal when symptoms of general anxiety were not 
controlled for. Region of significance testing found no significant differences at 
either one standard deviation below the mean (β = 1.2345, s.e. = 0.7766, z = 
1.5896, p = .112) or one standard deviation above the mean (β = -0.9713, s.e. = 
0.7766, z = -1.2506, p = .2111) on the afternoon cortisol slope.  No interaction 
was found between the DAT1-VNTR and the afternoon slope for girls.  DAT1 did 
not significantly interact with either the evening intercept or the morning slope to 
predict externalizing symptoms (See Table 11).  
Genetic analyses were rerun with Caucasian only subsample in order to 
address population stratification, the differences in ancestry that can cause 
differences in allelic frequencies and confound genetic findings when populations 
of different origins are studied together, and results were the same. 
Discussion 
 Integral to the treatment of complex psychological disorders such as 
externalizing disorders, is a greater understanding of the genetic and biological 
pathways that significantly impact them. The primary goal of the current study 
was to explore the association between diurnal cortisol, a hormone key to the 
HPA-axis stress response, and externalizing symptoms, as well as the moderating 
role of specific genetic variants on this association during middle childhood. 
Results suggest not only a link between diurnal cortisol and externalizing 
symptoms in boys, but confirmation that genetic polymorphisms moderate this 
association. This is the first study to empirically examine the moderating impact 
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of measured genes on the cortisol-externalizing dynamic and findings should 
encourage a continued exploration of the physiological etiology of symptoms of 
externalizing disorders. 
Placing the Findings in the Context of the Literature 
 The first part of the first hypothesis, that genetic polymorphisms on 
CRHR1, FKBP5, COMT, and DAT1 would be associated with externalizing 
symptoms was not supported. For the two HPA-axis genes, CRHR1 and FKBP5, 
this is not entirely unexpected in the absence of current literature directly relating 
either gene to externalizing outcomes. For the catecholamine genes, COMT and 
DAT1, this result is a little more surprising. The COMT Val allele in adolescents 
(DeYoung et al., 2010) and the Met allele in children (Albaugh et al., 2010; Caspi 
et al., 2008; Thapar et al., 2005) have been associated with symptoms of conduct 
disorder and antisocial behavior. Similarly, the 10-repeat of the DAT1-VNTR 
(Guo et al., 2007) and the 9-repeat (Young et al., 2003) have been associated with 
violent behavior and externalizing symptoms in children. However, lack of 
consistency across studies associating measured genes with complex traits are not 
uncommon (Colhoun, McKeigue, & Smith, 2003). Inconsistencies in this 
literature can result from issues of power, the bias in publication toward 
significant findings, or more theoretical issues such as population structure. 
Measured gene studies are performed all over the world with samples that are not 
necessarily consistent from one study to another in terms of ancestral background. 
Lack of replication may indicate that an association between gene and phenotype 
only exists for some populations and not others. 
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 The second half of the first hypothesis, that children lower on trait cortisol 
would demonstrate higher externalizing symptoms, was also not supported. In 
fact, my findings demonstrated the opposite pattern in boys and showed no 
significant association with externalizing symptoms in girls. Three of the four 
diurnal cortisol measures, the evening intercept, morning slope, and afternoon 
slope, were significantly associated with number of externalizing symptoms, but 
unlike the meta-analysis finding from Alink et al. (2008) for the middle childhood 
age group, higher levels of cortisol on these three measures were associated with 
higher externalizing symptoms. Differences in the methodology of the current 
study and the Alink meta-analysis may help explain the discrepancy in findings. 
Alink et al considered a broader range of “school-aged” children (5-12 years) and 
reported a different direction of effects for children under five. I examined a more 
narrow age range (7-8 years) and that may have contributed to the difference.  
Perhaps more importantly, I used trait cortisol measures, which have only 
been used in a handful of studies, as opposed to raw measures of cortisol. The 
difference in results may be because patterns of trait cortisol with externalizing 
symptoms are uniquely different from patterns of raw cortisol with externalizing 
symptoms. It may be that the pattern of hypocortisolism most often found in 
association with externalizing is largely due to state cortisol and that by separating 
out the two I have uncovered a different pattern associated specifically with trait 
cortisol. The single previous study to examine the association between trait 
cortisol and externalizing symptoms found lower cortisol to be associated with 
externalizing in boys, but their measurement of cortisol was limited to one sample 
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each day at waking (Shirtcliff et al., 2005). The one cortisol measure I did not find 
a significant main effect for was the morning intercept. Unlike the trait morning 
intercept, the trait afternoon slope and evening intercept have previously been 
found to have no significant additive genetic component in twin research (Van 
Hulle, Shirtcliff, Lemery-Chalfant, & Goldsmith, 2012). The differences between 
the Alink et al (2008) meta-analysis and Shirtcliff et al. (2005) may be because 
trait measures of afternoon and evening cortisol are uniquely able to capture 
differences in the HPA-axis stress response associated with the shared family 
environment. 
 The second hypothesis, that genetic variants on CRHR1, FKBP5, COMT, 
and DAT1 would moderate the association between diurnal cortisol and 
externalizing symptoms, was partially supported. CRHR1 SNP rs242924 
moderated the association between the morning cortisol intercept and 
externalizing in boys and girls. The marginal slope for GG carriers suggests that 
this group has higher externalizing symptoms at lower levels of morning cortisol 
compared to GG carriers at higher levels of morning cortisol. GG carriers and TT 
carriers were also found to be significantly different at lower levels of morning 
cortisol, with GG carriers demonstrating higher levels of externalizing and TT 
carriers demonstrating lower levels of externalizing when compared to each other. 
These results should be interpreted with caution. This is not only the first study to 
find this SNP as a moderator of the association between cortisol and 
externalizing, but is the first to associate CRHR1 with externalizing symptoms 
and disorders. CRHR1 has been found to moderate the association between 
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trauma and cortisol, such that the GG genotype and childhood maltreatment 
predicted higher reactive cortisol reactions for adult men, but those results are not 
directly comparable to these novel findings (Heim et al., 2009; Tryka et al., 2009).  
 There was no significant moderation by FKBP5 SNP rs1360780. This is in 
line with the absence of literature relating this gene with externalizing outcomes. 
FKBP5 has been related to both reactive (Ising et al., 2008; Luijk et al., 2010), 
and diurnal cortisol (Velders et al., 2011), but never as a moderator of cortisol and 
psychopathological outcomes. Due to the role FKBP5 plays in shutting down the 
HPA-axis stress response, it is possible that the impact it may have on the 
cortisol-externalizing association is more proximal and better modeled in a 
mediation framework or in a design relating it to a more immediate byproduct of 
the HPA-axis such as CRH or ACTH. 
 Similar to FKBP5, there was no significant moderation by COMT SNP 
rs4680. Unlike FKBP5, COMT has been associated with externalizing outcomes 
in children (Albaugh et al., 2010; Caspi et al., 2008; Thapar et al., 2005). It has 
also been associated with diurnal cortisol (Walder et al., 2010), although it has 
more frequently been associated with reactive HPA-axis functioning (Alexander 
et al., 2011; Jabbi et al., 2007). Perhaps the reason no association was found was 
because COMT has a greater impact on the HPA-axis response to a specific 
stressor than on daily cortisol functioning.  
 Finally, the DAT1-VNTR significantly moderated the cortisol-
externalizing association but only for boys. Specifically, the VNTR interacted 
with the morning intercept such that boys with the 9/9 genotype and lower 
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morning cortisol had marginally higher externalizing symptoms compared to 
those with the 9/10 and 10/10 genotypes. Similarly, boys with at least one 9-
repeat were found to have higher externalizing symptoms when they had less 
steep afternoon cortisol slopes and had fewer externalizing symptoms when they 
had steeper afternoon slopes. The relation between DAT1 and externalizing 
symptoms has previously been documented in the psychopathology literature 
(Guo et al., 2007; Vaughn et al., 2009; Young et al., 2003). The current study is 
the first to suggest that HPA-axis functioning assessed with diurnal cortisol may 
be an important component of the system. As with the findings for CRHR1, the 
results for DAT1 should be interpreted with caution. Only one previous study has 
associated this gene with reactive cortisol (Alexander et al., 2011) and none have 
associated it with diurnal cortisol. 
Implications 
 Findings contribute to the literature in three ways: 1) they begin to 
uncover a physiological pathway through which genetics and cortisol may 
contribute to the development of externalizing symptoms, 2) they suggest that this 
pathway may function uniquely for boys compared to girls, and 3) they suggest 
that this pathway functions independently of the association between anxiety 
symptoms and externalizing symptoms. One of the primary goals was to help 
unveil one of the biological mechanisms involved in the etiology of externalizing 
symptoms. The impact of genetic polymorphisms and diurnal cortisol furthers our 
understanding of those mechanisms. 
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 The finding that genes involved directly with the HPA-axis and that 
indirectly impact the HPA-axis through the dopaminergic system in the brain are 
associated with the cortisol-externalizing dynamic provide insight into how 
human physiology may contribute to psychopathology. CRHR1, as a gene that 
influences the number of CRH1 receptors, contributes to ACTH and cortisol 
levels in the brain. The specific function of SNP rs242924 is not currently known 
(Heim et al., 2009). However, this SNP has been found to be in high linkage 
disequilibrium with CRHR1 SNPs rs110402 and rs7209436 (Bradley et al., 2008). 
Together these three SNPs have been used to form haplotypes, of which the TAT 
variation has been found to be a protective factor from depression. Perhaps the 
finding in the current study of lower externalizing symptoms for TT carriers on 
rs242924 in the presence of lower morning cortisol is an indication of a broader 
protective effect for the previously studied haplotype beyond just depression. It is 
not yet clear how the interaction between low morning cortisol and CRHR1 
genotype may result in increased externalizing, but the dysregulation of multiple 
components of the HPA-axis, in this case, change in the number of CRH1 
receptors and lower levels of morning cortisol, may represent a form of additive 
risk for these children. 
 The path by which DAT1, by virtue of its role in dopaminergic 
functioning, interacts with cortisol to potentially impact externalizing is likely 
different than CRHR1.  The finding that cortisol, via both the morning intercept 
and afternoon slope, and the DAT1-VNTR are associated with externalizing 
symptoms is in line with research in rodents suggesting an interaction between the 
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HPA-axis and dopaminergic systems of the brain. In rats, evidence suggests the 
mesocortical dopamine system is involved in modulating HPA-axis activity in 
response to high or chronic stress (Sullivan & Dufresne, 2006). Rats exposed to 
chronic stress have also been found to have lower levels of dopamine 
transmission in the prefrontal cortex jointly with dyregulated HPA-axis 
functioning (Mizoguchi et al., 2008). This joint dysregulation has been associated 
with depressive behaviors in rats but it is conceivable that a similar joint 
dysfunction may be important to understanding the development of externalizing. 
The findings in the current study suggest the need to examine both irregular 
functioning in a single biological system, and the interaction of multiple systems 
and how they contribute to the development of psychopathological symptoms. 
 For the majority of findings, a significant sex interaction was found. 
Follow up analyses suggested these interactions were present for boys but not for 
girls. Boys (M = 6.89, SD = 4.55) had more externalizing symptoms than girls (M 
= 5.87, SD = 4.03), t(848) = 3.467, p = .001. The differences between boys and 
girls in the current study may simply be due to the higher number and greater 
range in symptoms found in this sample of boys compared to girls. Alternatively, 
biological or environmental factors may have a differential effect on boys than 
girls in the development of externalizing symptoms. Aggression was higher in 
boys during middle childhood compared to girls, which put them at higher risk for 
externalizing outcomes (Card et al., 2008). The higher rates of aggression and 
externalizing in boys may simply make biological differences in genes and 
cortisol easier to detect in this group, but it seems equally as likely that biological 
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differences in genes and cortisol are contributing to higher rates of aggression and 
externalizing and represent a gender difference in physiological functioning. Twin 
research on the etiology of externalizing has uncovered few genetic gender 
differences despite the higher levels of externalizing found in boys (Burt, 
Krueger, McGue, & Iacono, 2003; Hudziak et al., 2003). When twin studies have 
found a difference in the additive genetic influence on externalizing, boys have 
shown a greater additive genetic component compared to girls (Saudino, Ronald, 
& Plomin, 2005), but findings of a gender difference appear to be the exception 
not the rule. These findings lend credence to the hypothesis that findings were 
limited to boys in this study because of the greater variation in externalizing 
symptoms. At the very least, they suggest a need to test cortisol as a moderator of 
twin ACE models to see if it changes the genetic and environmental variance in 
externalizing differently by gender. 
 Integral to the theoretical basis was previous research suggesting different 
pathways for reactive and abnormal aggression. Symptoms of anxiety were 
controlled for in an attempt to differentiate between these two pathways but 
findings indicate no significant difference on genetic and cortisol associations 
with externalizing controlling for anxiety symptoms. Although anxiety symptoms 
significantly predicted externalizing symptoms, the pathway from anxiety 
symptoms to externalizing symptoms was independent of the pathway associating 
diurnal cortisol with externalizing. This independence suggests that cortisol may 
not be one of the biological mechanisms that separate children with comorbid 
anxiety and externalizing symptomology from more severely impaired 
  33 
counterparts who only suffer from externalizing (Walker et al., 1991). It was 
hypothesized in this study that controlling for anxiety would differentiate reactive 
from abnormal pathways from HPA-axis functioning to externalizing. The 
findings suggest that either controlling for anxiety symptoms was a poor method 
for differentiating the pathways or that these two pathways supported by the 
animal literature do not inform the development of psychopathology in humans. It 
is also possible that controlling for anxiety did not adequately capture differential 
etiology of externalizing problems, and it would be more effective to test a 
broader model of internalizing or to use a more person-centered approach.  
Limitations of the Current Study 
 The primary limitations are the concurrent nature of the design, the limited 
physiological measures for attempting to understand the biological etiology of 
externalizing symptoms, and the use of the measured gene approach to understand 
the role of genetics in the development of externalizing. The application of a 
longitudinal design would have clarified temporal precedence in the associations 
of genes, cortisol, and externalizing. Knowing, not only that changes in diurnal 
cortisol preceded changes in externalizing symptoms, but at what period of child 
development that diurnal cortisol shifted and how long after that shift they 
impacted externalizing levels would provide a far better understanding of the 
dynamic. Previous research has shown differences between concurrent and 
longitudinal associations between diurnal cortisol and mental health (Shirtcliff & 
Essex, 2008). By examining both concurrent and longitudinal findings, the picture 
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of how these physiological processes impact externalizing would be more 
complete. 
 The present study took two complex processes in human functioning, 
genetics and the HPA-axis, and analyzed two small aspects of those processes, 
variants on four measured genes and diurnal cortisol output. This simplified 
method allowed for testable hypotheses but the results must be placed within the 
larger biological framework. The HPA-axis is a complex system and cortisol, as 
the byproduct of that system, can be affected by other HPA-axis processes and 
other systems within the human body such as the dopaminergic and 
serotoninergic systems within the brain (Jankord & Herman, 2008). By only 
testing measured levels of diurnal cortisol and selected genetic variants, the full 
biological system within which these findings operate is not completely 
understood and the context of the broader system must be acknowledged when 
attempting to interpret the results.  
 Lastly, the measured gene approach to studying the impact of genetics on 
psychopathological outcomes has been criticized. The primary concerns of this 
method are that of replication and power of effect (Taber, Risch, & Meyers, 
2002). Some measured gene associations have proven difficult or impossible to 
replicate leading to questions of the validity of the method. The chance of 
findings that cannot be replicated in the current study was minimized by selecting 
variants from genes with known biological functions that impact HPA-axis 
functioning and that have previously been associated in the literature with 
externalizing symptoms, cortisol, or both. The issue remains, however, that the 
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associations tested in interaction with diurnal cortisol are novel and must be 
replicated in independent samples. The second issue with this method is one of 
meaning. The variants studied represent a miniscule fraction of the human 
genome. The question of whether or not the present findings represent meaningful 
differences within the context of a much more complicated biological system 
cannot be fully answered by the current study, but as with the issue of replication, 
the selection of biologically meaningful variants was done, in part, to help address 
this issue. 
Future Directions 
 Future research should expand on these findings by incorporating a 
longitudinal element in order to better understand the developmental impact of 
genes and cortisol throughout childhood. Other genes that impact the HPA-axis 
and the dopamine system should also be tested and the model should be expanded 
to consider other systems of neurotransmitters that impact the HPA-axis, such as 
the serotonergic system. Trait cortisol measures should be compared with raw 
cortisol measures in order to better understand the similarities and differences in 
the pattern of results from each. In addition to expanding upon the biological 
measures, future studies should consider environmental measures. The biological 
systems that effect externalizing do not exist in a vacuum and understanding the 
psychosocial environment in relation to these biological systems is integral to 
fully understanding how externalizing symptoms and disorders develop. For 
instance, family conflict has been shown to impact diurnal cortisol levels in young 
children (Slatcher & Robles, 2012). Finally, the comorbidity between 
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externalizing and anxiety symptoms should be more fully explored, along with 
symptoms of depression in order to understand the unique and similar biological 
pathways between externalizing and internalizing disorders, as well as to further 
explore the implications of the aggression pathways found in the animal literature 
on human development. One method that could prove effective in this endeavor 
going forward, is a person-centered approach. Instead of taking the symptom-
based approach used here to understand the associations between cortisol and 
externalizing, latent class groups would be formed based on different patterns of 
externalizing and internalizing within individuals. Researchers could then look at 
how genes and cortisol predict latent class group membership. 
 Finally, the current study took a moderating approach, theorizing that the 
interaction between genetic variants and cortisol would impact externalizing. In 
order to understand the full picture of how these two biological mechanisms 
interact to influence externalizing, future research should test cortisol as an 
endophenotype, a more proximal phenotype directly linked to both genotype and 
outcome phenotype, in a mediation model. Especially for genes such as CRHR1 
and FKBP5, that have functions that may directly impact HPA-axis functioning, 
testing whether cortisol mediates the association between gene and externalizing 
is necessary to fully understanding the biological system at play in the 
development of externalizing disorders. 
Conclusions 
 Findings represent a step forward in understanding the biological etiology 
of externalizing symptoms by demonstrating an association between trait diurnal 
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cortisol and symptoms of externalizing disorders, moderated by functional genetic 
variants. Understanding this pathway has the potential to inform pharmacological 
treatment and hopefully will encourage future research that can build upon the 
findings to better understand the biological systems at play for both prevention 
and intervention purposes. The current study was not able to support a distinction 
between a reactive aggression and an abnormal aggression pathway, but supports 
the role of cortisol in the etiology of externalizing and illustrates the potential of 
targeting the HPA axis in pharmacological interventions. By increasing our 
knowledge of biological pathways to psychopathology, I hope to address the 
significant health concern that externalizing symptoms and disorders impose, and 
take a step forward in a line of research with the potential to have a positive 
impact on children. 
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Table 1: Genotype Frequencies for Candidate Genes 
CRHR1 
(rs242924) 
 FKBP5 
(rs1360780) 
 COMT 
(rs4680) 
 DAT1-
VNTR 
 
Total 1168  1142  1192  866 
AA 249 TT 103 AA 317 nine/nine 43 
AC 565 CT 430 AG 581 nine/ten 316 
CC 354 CC 609 GG 294 ten/ten 489 
        
Hardy-
Weinberg 
p < .05  p < .05  p < 
.05 
 p < 
.05 
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Table 2: Descriptive Statistics 
  N Mean SD Min Max 
Morning Cortisol Intercept 869 3.89 0.31 2.56 5.06 
Evening Cortisol Intercept 869 2.34 0.51 0.76 4.51 
Morning Cortisol Slope 869 -0.13 0.02 -0.21 -0.04 
Evening Cortisol Slope 869 -0.10 0.06 -0.30 0.12 
DISC General Anxiety 
Symptoms 1598 1.60 1.89 0.00 12.00 
DISC Externalizing 
Symptoms 1597 6.58 4.54 0.00 26.00 
Note. DISC stands for Diagnostic Interview Schedule 
for Children IV   
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Table 4: Main Effect of Genes on Externalizing Symptoms 
 
  
  51 
Β S.E. df
Hypothesis 1: CRHR1
Intercept 6.507*** 0.229 416.342
Sex -1.265*** 0.245 378.243
DISC Anxiety 0.468*** 0.063 170.384
rs242924 -0.177 0.178 1079.616
Hypothesis 1: FKBP5
Intercept 6.537*** 0.323 270.334
Sex -1.102** 0.338 249.079
DISC Anxiety 0.381*** 0.077 68.851
rs1360780 -0.23552 0.251 563.910
Hypothesis 1: COMT
Intercept 6.499*** 0.223 423.864
Sex -1.323*** 0.241 381.320
DISC Anxiety 0.472*** 0.062 181.322
rs4680 -0.027 0.169 1112.608
Hypothesis 1: DAT1
Intercept 6.369*** 0.311 338.320
Sex -1.063** 0.307 274.836
DISC Anxiety 0.406*** 0.074 155.023
DAT1-VNTR 0.149 0.253 782.517
Externalizing
Symptoms
Note.  + p  < .10, * p < .05, ** p  < .01, *** p < .001. 
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Table 5:  Diurnal Cortisol Measures on Externalizing Symptoms 
 
 
  
Β S.E. df
Hypothesis 1: Morning CORT Intercept
Intercept 6.312** 1.817058 800.3287
Sex -1.102*** 0.307349 324.1948
DISC Anxiety 0.402*** 0.077661 142.9056
Morning CORT Intercept 0.002 0.461481 792.0098
Hypothesis 1: Evening CORT Intercept
Intercept 3.651** 1.067 471.178
Sex -1.06** 0.305 321.708
DISC Anxiety 0.401*** 0.078 143.638
Evening CORT Intercept 1.124** 0.436 477.577
Evening CORT Intercept*Sex -1.473** 0.548 527.364
Hypothesis 1: Afternoon CORT Slope
Intercept 7.122*** 0.423 477.712
Sex -1.073*** 0.303 314.278
DISC Anxiety 0.404*** 0.078 145.990
Afternoon CORT Slope 8.464* 3.507 518.597
Afternoon CORT Slope*Sex -10.755* 4.373 575.296
Hypothesis 1: Morning CORT Slope
Intercept 9.049*** 1.299 518.175
Sex -1.068*** 0.303 316.206
DISC Anxiety 0.400*** 0.078 145.719
Morning CORT Slope 21.436* 9.984 514.545
Morning CORT Slope*Sex -29.788* 12.669 594.951
Note.  + p  < .10, * p < .05, ** p  < .01, *** p < .001. 
Externalizing
Symptoms
52 
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Table 6: Interactions with CRHR1 and Cortisol Measures on Externalizing 
Symptoms 
 
 
Β S.E. df
Hypothesis 2: CRHR1 x Morning CORT Intercept
Intercept 6.526** 2.091 597.528
Sex -1.153** 0.337 229.937
DISC Anxiety 0.465*** 0.086 96.911
Morning CORT Intercept -0.081 0.532 594.645
rs242924 -0.839*** 0.238 569.226
rs242924*Morning CORT Intercept 1.401* 0.694 548.332
Hypothesis 2: CRHR1 x Evening CORT Intercept
Intercept 5.994*** 0.821 566.102
Sex -1.150** 0.338 232.178
DISC Anxiety 0.462*** 0.086 96.036
Evening CORT Intercept 0.092 0.331 532.585
rs242924 -0.857*** 0.241 565.198
rs242924*Evening CORT Intercept -0.067 0.397 558.149
Hypothesis 2: CRHR1 x Morning CORT Slope
Intercept 6.496*** 0.987 608.001
Sex -1.176** 0.337 231.599
DISC Anxiety 0.462*** 0.086 95.109
Morning CORT Slope 2.165 7.295 580.424
rs242924 -0.887*** 0.240 569.710
rs242924*Morning CORT Slope -12.464 9.473 538.770
Hypothesis 2: CRHR1 x Afternoon CORT Slope
Intercept 6.270*** 0.384 403.672
Sex -1.164** 0.337 231.507
DISC Anxiety 0.463*** 0.086 96.303
Afternoon CORT Slope 0.553 2.514 534.457
rs242924 -0.895*** 0.240 566.732
rs242924*Afternoon CORT Slope -3.899 3.234 508.010
Externalizing
Symptoms
Note.  + p  < .10, * p < .05, ** p  < .01, *** p < .001. 
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Table 7: Interactions with FKBP5 and Cortisol Measures on Externalizing 
Symptoms 
 
 
Β S.E. df
Hypothesis 2: FKBP5 x Morning CORT Intercept
Intercept 3.791 4.797 224.643
Sex -0.787 0.515 248.740
DISC Anxiety 0.379** 0.140 67.176
Morning CORT Intercept 0.562 1.242 223.205
rs1360780 0.118 0.442 241.102
rs1360780*Morning CORT Intercept -0.454 1.613 222.908
Hypothesis 2: FKBP5 x Evening CORT Intercept
Intercept 5.370*** 1.473 242.046
Sex -0.774 0.514 249.314
DISC Anxiety 0.370* 0.140 63.182
Evening CORT Intercept 0.286 0.683 237.479
rs1360780 0.090 0.505 245.976
rs1360780*Evening CORT Intercept -0.168 0.805 249.465
Hypothesis 2: FKBP5 x Morning CORT Slope
Intercept 5.559* 2.291 235.853
Sex -0.786 0.515 249.907
DISC Anxiety 0.381** 0.141 63.722
Morning CORT Slope -2.709 16.127 230.550
rs1360780 0.281 0.482 243.641
rs1360780*Morning CORT Slope 12.746 20.024 245.537
Hypothesis 2: FKBP5 x Afternoon CORT Slope
Intercept 6.148*** 0.836 244.681
Sex -0.786 0.515 249.050
DISC Anxiety 0.370* 0.139 62.767
Afternoon CORT Slope 1.388 4.889 240.680
rs1360780 0.047 0.488 243.473
rs1360780*Afternoon CORT Slope -2.873 6.215 245.231
Symptoms
Note.  + p  < .10, * p < .05, ** p  < .01, *** p < .001. 
Externalizing
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Table 8: Interactions with COMT and Cortisol Measures on Externalizing 
Symptoms 
 
  
Β S.E. df
Hypothesis 2: COMT x Morning CORT Intercept
Intercept 5.852** 2.102 586.040
Sex -1.198** 0.343 230.800
DISC Anxiety 0.469*** 0.086 106.815
Morning CORT Intercept 0.061 0.535 581.549
rs4680 -0.129 0.251 189.441
rs4680*Morning CORT Intercept 0.300 0.726 323.613
Hypothesis 2: COMT x Evening CORT Intercept
Intercept 5.730*** 0.831 531.353
Sex -1.182** 0.344 230.887
DISC Anxiety 0.469*** 0.086 106.534
Evening CORT Intercept 0.151 0.334 498.065
rs4680 -0.136 0.251 191.094
rs4680*Evening CORT Intercept 0.090 0.484 310.187
Hypothesis 2: COMT x Morning CORT Slope
Intercept 6.392*** 1.006 575.733
Sex -1.197** 0.343 233.251
DISC Anxiety 0.465*** 0.086 105.818
Morning CORT Slope 2.287 7.469 539.868
rs4680 -0.143 0.250 187.734
rs4680*Morning CORT Slope -6.690 10.443 362.143
Hypothesis 2: COMT x Afternoon CORT Slope
Intercept 6.097*** 0.384 387.136
Sex -1.193** 0.343 231.205
DISC Anxiety 0.471*** 0.086 106.347
Afternoon CORT Slope 0.205 2.507 514.892
rs4680 -0.137 0.251 189.303
rs4680*Afternoon CORT Slope 1.348 3.302 345.247
Note.  + p  < .10, * p < .05, ** p  < .01, *** p < .001. 
Externalizing
Symptoms
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Table 9: Interaction with DAT1 and the Morning Cortisol Intercept on 
Externalizing Symptoms 
 
 
 
  
Β S.E. df
Hypothesis 2: DAT1 x Morning CORT Intercept
Intercept 15.324* 6.409 195.001
Sex -0.805 0.581 160.723
DISC Anxiety 0.445*** 0.111 106.645
Morning CORT Intercept -2.364 1.640 193.763
DAT1-VNTR -0.094 0.542 207.440
DAT1-VNTR*Morning CORT Intercept 3.521+ 1.884 209.501
Morning CORT Intercept*Sex 3.193 1.956 224.094
DAT1-VNTR*Sex -0.393 0.686 250.839
DAT1-VNTR*Morning CORT Intercept*Sex -4.775* 2.313 270.893
Hypothesis 2: DAT1 x Morning CORT Intercept - Boys Only
Intercept 17.401* 6.505 26.520
DISC Anxiety 0.589** 0.195 52.730
Morning CORT Intercept -3.035+ 1.669 24.974
DAT1-VNTR 0.211 0.623 19.632
DAT1-VNTR*Morning CORT Intercept 3.907+ 2.039 26.919
Hypothesis 2: DAT1 x Morning CORT Intercept - Girls Only
Intercept 5.042 4.499 96.334
DISC Anxiety 0.338** 0.117 137.410
Morning CORT Intercept 0.112 1.163 96.363
DAT1-VNTR -0.486 0.444 60.798
DAT1-VNTR*Morning CORT Intercept -0.989 1.386 99.209
Externalizing
Symptoms
Note.  + p  < .10, * p < .05, ** p  < .01, *** p < .001. 
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Table 10: Interaction with DAT1 and the Afternoon Cortisol Slope on 
Externalizing Symptoms 
 
 
 
 
Β S.E. df
Hypothesis 2: DAT1 x Afternoon CORT Slope
Intercept 8.163*** 0.863 161.666
Sex -0.985+ 0.579 153.736
DISC Anxiety 0.451*** 0.113 105.452
Afternoon CORT Slope 19.471** 6.600 180.157
DAT1-VNTR -0.047 0.530 194.992
DAT1-VNTR*Afternoon CORT Slope -14.627+ 7.959 223.473
Afternoon CORT Slope*Sex -24.179** 7.643 184.284
DAT1-VNTR*Sex -0.332 0.681 234.352
DAT1-VNTR*Afternoon CORT Slope*Sex 22.147* 9.601 269.329
Hypothesis 2: DAT1 x Afternoon CORT Slope - Boys Only
Intercept 8.075*** 0.851 26.695
DISC Anxiety 0.587** 0.201 56.559
Afternoon CORT Slope 21.560** 6.181 43.594
DAT1-VNTR 0.132 0.591 22.546
DAT1-VNTR*Afternoon CORT Slope -18.381* 8.393 66.113
Hypothesis 2: DAT1 x Afternoon CORT Slope - Girls Only
Intercept 5.058*** 0.646 207.997
DISC Anxiety 0.361** 0.116 170.501
Afternoon CORT Slope -3.689 4.186 205.456
DAT1-VNTR -0.435 0.440 207.950
DAT1-VNTR*Afternoon CORT Slope 7.172 5.442 194.092
Externalizing
Symptoms
Note.  + p  < .10, * p < .05, ** p  < .01, *** p < .001. 
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Table 11: Interactions with DAT1 and Cortisol Measures on Externalizing 
Symptoms 
  
 
 
 
 
 
 
 
  
Β S.E. df
Hypothesis 2: DAT1 x Evening CORT Intercept
Intercept 5.723*** 1.198 355.371
Sex -1.024* 0.455 137.810
DISC Anxiety 0.457*** 0.110 100.246
Evening CORT Intercept 0.228 0.502 324.028
DAT1-VNTR -0.312 0.356 336.666
DAT1-VNTR*Evening CORT Intercept 0.081 0.600 351.056
Hypothesis 2: DAT1 x Morning CORT Slope
Intercept 7.094*** 1.697 334.488
Sex -1.035* 0.456 138.147
DISC Anxiety 0.456*** 0.109 98.374
Morning CORT Slope 6.549 12.338 323.301
DAT1-VNTR -0.330 0.356 329.966
DAT1-VNTR*Morning CORT Slope -5.512 15.685 326.091
Externalizing
Symptoms
Note.  + p  < .10, * p < .05, ** p  < .01, *** p < .001. 
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Figure 3 
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Figure 6 
 
 
